Wealthcare Advisory Partners’s ResMed RMD Stock Holding History

Wealthcare Advisory Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-267	Closed	-$52K	–	1583
2021 Q1	$52K	Buy	+267	New	+$53.5K	﹤0.01%	862
2020 Q2	–	Sell	-245	Closed	-$36K	–	1131
2020 Q1	$36K	Hold	245	–	–	0.01%	579
2019 Q4	$38K	Hold	245	–	–	﹤0.01%	611
2019 Q3	$33K	Hold	245	–	–	﹤0.01%	631
2019 Q2	$30K	Hold	245	–	–	﹤0.01%	625
2019 Q1	$25K	Hold	245	–	–	﹤0.01%	609
2018 Q4	$28K	Hold	245	–	–	0.01%	561
2018 Q3	$28K	Hold	245	–	–	0.01%	592
2018 Q2	$25K	Hold	245	–	–	﹤0.01%	619
2018 Q1	$24K	Buy	+245	New	+$23.2K	0.01%	550

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wealthcare Advisory Partners's RMD Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of ResMed (RMD) in Q2 2021, closing a stake of 267 shares — an estimated $52K sold.

Wealthcare Advisory Partners first reported a position in RMD in Q1 2018 and held it in 10 quarters. The position peaked at $52K in Q1 2021. 661 funds tracked by Wall St. Rank hold RMD as of Q2 2021.

Wealthcare Advisory Partners reported no remaining ResMed position as of Q2 2021 after selling out during the quarter.
Wealthcare Advisory Partners sold 267 ResMed shares in Q2 2021, an estimated $52K.
Wealthcare Advisory Partners first reported a position in ResMed in Q1 2018 and held it in 10 quarters.
Wealthcare Advisory Partners's ResMed position peaked at $52K in Q1 2021.
661 funds tracked by Wall St. Rank held ResMed as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.